Bioventus Inc.BVSNASDAQ

Revenue (LTM)

$568M

-0.9% YoY

Net Income (LTM)

$23M

+167.8% YoY

Free Cash Flow

$71M

Revenue CAGR (5Y)

+7.2%

—Marginsstable

FCF$0.1B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	431	512↑18.8%	512↑0.0%	573↑11.9%	568↓0.9%
Gross Profit	303	331↑9.4%	328↓0.9%	388↑18.3%	382↓1.5%
Operating Income	12	-167↓1486.6%	-82↑51.1%	-12↑85.3%	59↑588.7%
Net Income	19	-159↓919.1%	-156↑1.6%	-34↑78.5%	23↑167.8%
EBITDA	45	-122↓367.4%	-23↑81.0%	39↑270.0%	106↑169.1%
EPS Diluted	-0.15	-2.59↓1626.7%	-2.49↑3.9%	-0.52↑79.1%	0.33↑163.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	44	30↓31.3%	37↑22.5%	42↑12.5%	51↑23.2%
Total Current Assets	263	273↑3.6%	268↓1.7%	276↑2.8%	273↓1.0%
Total Assets	1,226	1,373↑12.0%	811↓40.9%	728↓10.2%	684↓6.1%
Total Current Liabilities	181	304↑68.1%	175↓42.3%	210↑19.9%	160↓23.8%
Total Liabilities	692	960↑38.8%	590↓38.6%	542↓8.0%	455↓16.1%
Total Equity	459	325↓29.1%	174↓46.6%	148↓14.8%	184↑24.4%
Total Debt	358	418↑16.9%	395↓5.6%	336↓15.0%	311↓7.2%
Net Debt	314	388↑23.6%	358↓7.7%	294↓17.8%	260↓11.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	23	-14↓158.9%	15↑213.3%	39↑152.8%	74↑90.7%
Capital Expenditure	-21	-1↑92.9%	-7↓398.1%	-1↑86.3%	-3↓154.7%
Free Cash Flow	2	-15↓814.7%	8↑153.2%	38↑373.4%	71↑89.0%
Stock-Based Comp	20	18↓11.4%	3↓84.5%	10↑269.5%	0
Net Change in Cash	12	-67↓644.5%	5↑107.6%	5↓9.9%	10↑109.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance